NASDAQ:EGLT

Egalet Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$0.0080
0.00 (0.00 %)
(As of 03/1/2019)
Add
Compare
Today's Range
$0.01
$0.01
50-Day Range
$0.01
$0.33
52-Week Range
$0.03
$1.57
VolumeN/A
Average Volume853,425 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive EGLT News and Ratings via Email

Sign-up to receive the latest news and ratings for Egalet and its competitors with MarketBeat's FREE daily newsletter.


Egalet logo

About Egalet

Egalet Corporation, a specialty pharmaceutical company, develops, manufactures, and commercializes treatments for patients with pain and other conditions. It has licensed three approved pain products, such as SPRIX Nasal Spray, a non-steroidal anti-inflammatory drug indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level; OXAYDO, an immediate-release oxycodone product designed to discourage abuse via snorting for the management of acute and chronic pain severe enough to require an opioid analgesic, and for which alternative treatments are inadequate; and ARYMO ER, an extended-release (ER) morphine product formulated with abuse-deterrent (AD) properties for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. The company is also developing Egalet-002, a Guardian Technology AD, ER, oral oxycodone formulation, which is in Phase III clinical trials for the same indication as ARYMO ER. In addition, its other products include Egalet-003, an AD stimulant product candidate; and Egalet-004, an AD, ER hydrocodone-based product candidate. The company has a collaboration and license agreement with Acura Pharmaceuticals, Inc. to commercialize OXAYDO tablets; and Septodont, Inc. to promote SPRIX Nasal Spray. Egalet Corporation was founded in 2010 and is headquartered in Wayne, Pennsylvania.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.99 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Egalet (NASDAQ:EGLT) Frequently Asked Questions

What stocks does MarketBeat like better than Egalet?

Wall Street analysts have given Egalet a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Egalet wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Egalet's earnings last quarter?

Egalet (NASDAQ:EGLT) announced its quarterly earnings data on Wednesday, August, 8th. The specialty pharmaceutical company reported ($0.22) earnings per share for the quarter, beating analysts' consensus estimates of ($0.28) by $0.06. The specialty pharmaceutical company had revenue of $7.44 million for the quarter, compared to the consensus estimate of $8.64 million.
View Egalet's earnings history
.

Who are Egalet's key executives?

Egalet's management team includes the following people:
  • Mr. Robert S. Radie, Pres, CEO & Director (Age 55)
  • Mr. Stanley J. Musial, Exec. VP, CFO & Sec. (Age 57)
  • Dr. Mark Strobeck, Exec. VP & COO (Age 47)
  • Ms. Barbara A. Carlin, Sr. VP & Chief Accounting Officer (Age 43)
  • Dr. Karsten Lindhardt M.Sc., Ph.D., Chief Scientific Officer (Age 46)

Who are some of Egalet's key competitors?

What other stocks do shareholders of Egalet own?

What is Egalet's stock symbol?

Egalet trades on the NASDAQ under the ticker symbol "EGLT."

What is Egalet's stock price today?

One share of EGLT stock can currently be purchased for approximately $0.01.

What is Egalet's official website?

The official website for Egalet is www.egalet.com.

Where are Egalet's headquarters?

Egalet is headquartered at 600 LEE ROAD SUITE 100, WAYNE PA, 19087.

How can I contact Egalet?

Egalet's mailing address is 600 LEE ROAD SUITE 100, WAYNE PA, 19087. The specialty pharmaceutical company can be reached via phone at 610-833-4200 or via email at [email protected]


This page was last updated on 9/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.